BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 7696180)

  • 1. The subunit composition of NF-kappa B complexes changes during B-cell development.
    Grumont RJ; Gerondakis S
    Cell Growth Differ; 1994 Dec; 5(12):1321-31. PubMed ID: 7696180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of nuclear factor-kappa B during primary B cell differentiation.
    Kistler B; Rolink A; Marienfeld R; Neumann M; Wirth T
    J Immunol; 1998 Mar; 160(5):2308-17. PubMed ID: 9498771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualization of the endogenous NF-kappa B p50 subunit in the nucleus of follicular dendritic cells in germinal centers.
    Feuillard J; Körner M; Fourcade C; Costa A; Binet JL; Debré P; Raphael M
    J Immunol; 1994 Jan; 152(1):12-21. PubMed ID: 8254185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB.
    Neumann M; Wohlleben G; Chuvpilo S; Kistler B; Wirth T; Serfling E; Schimpl A
    J Immunol; 1996 Dec; 157(11):4862-9. PubMed ID: 8943389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.
    Grumont RJ; Richardson IB; Gaff C; Gerondakis S
    Cell Growth Differ; 1993 Sep; 4(9):731-43. PubMed ID: 8241021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
    Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma modulates the lipopolysaccharide-induced expression of AP-1 and NF-kappa B at the mRNA and protein level in human monocytes.
    de Wit H; Hoogstraten D; Halie RM; Vellenga E
    Exp Hematol; 1996 Feb; 24(2):228-35. PubMed ID: 8641346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
    Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
    Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.
    Marienfeld R; Neumann M; Chuvpilo S; Escher C; Kneitz B; Avots A; Schimpl A; Serfling E
    Eur J Immunol; 1997 Jul; 27(7):1601-9. PubMed ID: 9247567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells.
    Ammon C; Mondal K; Andreesen R; Krause SW
    Biochem Biophys Res Commun; 2000 Feb; 268(1):99-105. PubMed ID: 10652220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
    Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
    Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B.
    Costello R; Lipcey C; Algarté M; Cerdan C; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Apr; 4(4):329-39. PubMed ID: 8098618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic control of nuclear factor-kappa B activation by the T cell receptor complex: role of tumor necrosis factor alpha.
    Pimentel-Muiños FX; Mazana J; Fresno M
    Eur J Immunol; 1995 Jan; 25(1):179-86. PubMed ID: 7843230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D; Rizzo CA; Dorfman K; Bravo R
    EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vomitoxin (deoxynivalenol) on transcription factor NF-kappa B/Rel binding activity in murine EL-4 thymoma and primary CD4+ T cells.
    Ouyang YL; Li S; Pestka JJ
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):328-36. PubMed ID: 8887449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Rel-A and c-Rel protein complexes are differentially distributed within human thymocytes.
    Feuillard J; Dargemont C; Ferreira V; Tarantino N; Debré P; Raphael M; Körner M
    J Immunol; 1997 Mar; 158(6):2585-91. PubMed ID: 9058790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.
    Wulczyn FG; Naumann M; Scheidereit C
    Nature; 1992 Aug; 358(6387):597-9. PubMed ID: 1501714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.
    Aoudjit F; Brochu N; Bélanger B; Stratowa C; Hiscott J; Audette M
    Cell Growth Differ; 1997 Mar; 8(3):335-42. PubMed ID: 9056676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation.
    Lernbecher T; Müller U; Wirth T
    Nature; 1993 Oct; 365(6448):767-70. PubMed ID: 7692309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.